WASH debuts on MAI, targeting 160 new branches for 2026-2027 
Shoucheng Holdings Launches Robot Tech Experience Store Naming Event 
EdgePoint Marks Five Years of Building ASEAN’s Digital Connectivity, with 16,000th site milestone 
Think Business, Think Hong Kong returns to Milan to deepen Hong Kong-Italy business ties 
Doubleview Gold Corp. Closes Final Tranche of Non-Brokered Private Placement for Gross Proceeds of $7,181,400 AXIM Biotechnologies Partners with Arizona State University to Determine Antibody Levels Against COVID-19
Company develops COVID-19 “Correlate of Protection” research to measure levels of neutralizing antibodies which protect…
Morphic Announces Participation in Upcoming Investor Conferences
WALTHAM, Mass., Nov. 16, 2021 (GLOBE NEWSWIRE) — Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing…
Hepion Pharmaceuticals and FibroFind Announce Anti-Cancer Activity of CRV431 in a Nonclinical Liver Cancer Study
EDISON, N.J., Nov. 16, 2021 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage…
European Medicines Agency Committee for Medicinal Products for Human Use (CHMP) Recommends Approval of Tecovirimat
– Broader Indication to Include Smallpox, Monkeypox, Cowpox, and Vaccinia Complications – NEW YORK, Nov….
Rakovina Therapeutics Partners with St. Baldrick’s Foundation to Research and Develop New Treatments for Childhood Bone Cancer
VANCOUVER, British Columbia, Nov. 16, 2021 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSXV: RKV) (“the…
CRISPR Therapeutics and ViaCyte, Inc. to Start Clinical Trial of the First Gene-Edited Cell Replacement Therapy for Treatment of Type 1 Diabetes
-Initiation of patient enrollment expected by year-end- ZUG, Switzerland and CAMBRIDGE, Mass. and SAN DIEGO,…
VistaGen Therapeutics to Present at the Jefferies London Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Nov. 16, 2021 (GLOBE NEWSWIRE) — VistaGen Therapeutics, Inc. (NASDAQ: VTGN),…
Oncotelic Announces Successful Completion of the Safety Evaluation of a TGF-β Inhibitor (OT-101) and IL-2 (Aldesleukin) in Phase 1 Combination Trial in Solid Tumor Cancers
AGOURA HILLS, CA, Nov. 16, 2021 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc. (“Oncotelic” or the…
Optinose Announces Pricing of Public Offering of Common Stock
YARDLEY, Pa., Nov. 16, 2021 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical company focused on…
Abyssinia Biologics Debuts Data on Ultra-sensitive Plasma Immunoassay for Key Synaptotoxin in Alzheimer’s Disease Pathogenesis
Assay developed using Abyssinia proprietary antibodies shows promise as sensitive and specific companion diagnostic Further…
AGTC Appoints Abraham Scaria, Ph.D., as Chief Science Officer
With 25+ years of experience, Dr. Scaria has led numerous gene therapy programs from early…
Coya Therapeutics Announces Successful Completion of Pre-IND Meeting with FDA on COYA101 for the Treatment of Amyotrophic Lateral Sclerosis
Plans to submit an IND to support a Phase 2b clinical trial for COYA101 HOUSTON,…
SOTIO Expands its Antibody-Drug Conjugate Pipeline with Exclusive Collaboration and License Agreement with LegoChem Biosciences
SOTIO Biotech licenses LegoChem Biosciences (LCB) technology for five new antibody-drug conjugate (ADC) programs Rights…
Erasca to Present at the Evercore ISI 4th Annual HealthCONx Conference
SAN DIEGO, Nov. 16, 2021 (GLOBE NEWSWIRE) — Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision…
BetterLife Obtains TD-0148A Behavioural Pharmacology Data Confirming its Projected Non-hallucinogenic Property
VANCOUVER, British Columbia, Nov. 16, 2021 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the…
Reflect Scientific Inc. Releases Third Quarter 2021 Financials
OREM, Utah., Nov. 16, 2021 (GLOBE NEWSWIRE) — Reflect Scientific, Inc. (OTCQB: RSCF), a provider…
Vaxart Announces Publication of Complete Data from Preclinical COVID-19 Oral Vaccine Hamster Challenge Study in Journal of Infectious Diseases
Study demonstrates oral vaccination significantly reduces viral titers in the lung and protects against COVID-19…
Takeda’s Area Offices in Dubai, United Arab Emirates Certified Sustainable and Inaugurated
Takeda Pharmaceuticals Company (“Takeda”), a global, values-based, R&D-driven biopharmaceutical company, hosted the formal inauguration of…
Abeona Therapeutics Announces Participation at the Jefferies London Healthcare Conference
NEW YORK and CLEVELAND, Nov. 16, 2021 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO),…
Mydecine Reports Third Quarter 2021 Financial Results and Provides Business Update
—To Launch Phase 2/3 Smoking Cessation Clinical Trial with Johns Hopkins University (JHU) Signed 5-Year…